Double redirects

Jump to navigation Jump to search

This page lists pages that redirect to other redirect pages. Each row contains links to the first and second redirect, as well as the target of the second redirect, which is usually the "real" target page to which the first redirect should point. Crossed out entries have been solved.

Showing below up to 50 results in range #1,051 to #1,100.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Carcinosarcoma of the uterus → Mixed Mullerian tumor → Mixed mullerian tumor
  2. Sarcomatoid carcinoma of the uterus → Mixed Mullerian tumor → Mixed mullerian tumor
  3. Malignant mesodermal mixed tumor → Mixed Mullerian tumor → Mixed mullerian tumor
  4. Metaplastic carcinoma → Mixed Mullerian tumor → Mixed mullerian tumor
  5. Combined fat and carbohydrate-induced hyperlipemia → Mixed hyperlipoproteinemia → Hyperlipoproteinemia type 5
  6. Familial hyperchylomicronemia with hyperprebetalipoproteinemia → Mixed hyperlipoproteinemia → Hyperlipoproteinemia type 5
  7. Late-onset hyperchylomicronemia → Mixed hyperlipoproteinemia → Hyperlipoproteinemia type 5
  8. Late onset hyperchylomicronemia → Mixed hyperlipoproteinemia → Hyperlipoproteinemia type 5
  9. Mixed hyperlipemia → Mixed hyperlipoproteinemia → Hyperlipoproteinemia type 5
  10. Type V hyperlipidemia → Mixed hyperlipoproteinemia → Hyperlipoproteinemia type 5
  11. Monoblastic leukemia → Monocytic leukemia → AML
  12. Monocytic leukemias → Monocytic leukemia → AML
  13. Monocytic leukaemia → Monocytic leukemia → AML
  14. Mononuclear → Mononuclear cells → Monocyte
  15. Urticaria-deafness-amyloidosis → Muckle-Wells syndrome → Cryopyrin-associated periodic syndrome
  16. Muckle-Wells Syndrome → Muckle-Wells syndrome → Cryopyrin-associated periodic syndrome
  17. Multiple endocrine neoplasia type 2b → Multiple endocrine neoplasia type 2a → Multiple endocrine neoplasia type 2
  18. MEA type 4 → Multiple endocrine neoplasia type 4 → Multiple endocrine neoplasia type 1 pathophysiology#MEN type 4
  19. Multiple endocrine neoplasms type 4 → Multiple endocrine neoplasia type 4 → Multiple endocrine neoplasia type 1 pathophysiology#MEN type 4
  20. Multiple endocrine adenomatosis, type 4 → Multiple endocrine neoplasia type 4 → Multiple endocrine neoplasia type 1 pathophysiology#MEN type 4
  21. MEN4 → Multiple endocrine neoplasia type 4 → Multiple endocrine neoplasia type 1 pathophysiology#MEN type 4
  22. Mycobacterium avium-intracellulare complex → Mycobacterium avium-intracellulare → Mycobacterium avium complex
  23. Mycophenolate mofetil → Mycophenolic acid → Mycophenolate sodium
  24. Cellcept → Mycophenolic acid → Mycophenolate sodium
  25. Myfortic → Mycophenolic acid → Mycophenolate sodium
  26. M. genitalium → Mycoplasma genitalium → Mycoplasma genitalium infection
  27. Leukemia, Myeloid → Myeloid leukemia → AML
  28. Myelogenous leukemia → Myeloid leukemia → AML
  29. Myeloid (Granulocytic) Leukemias → Myeloid leukemia → AML
  30. Myeloid leukaemia → Myeloid leukemia → AML
  31. Myeloproliferative Diseases → Myeloproliferative disease → Myeloproliferative neoplasm
  32. Myeloproliferative disorder → Myeloproliferative disease → Myeloproliferative neoplasm
  33. Myeloproliferative syndrome → Myeloproliferative disease → Myeloproliferative neoplasm
  34. Myeloproliferation → Myeloproliferative disease → Myeloproliferative neoplasm
  35. Myeloproliferative → Myeloproliferative disease → Myeloproliferative neoplasm
  36. Myeloproliferative disorders → Myeloproliferative disease → Myeloproliferative neoplasm
  37. Myeloproliferative diseases → Myeloproliferative disease → Myeloproliferative neoplasm
  38. Chronic myeloproliferative disorders → Myeloproliferative disease → Myeloproliferative neoplasm
  39. Myeloproliferative Disorders → Myeloproliferative disease → Myeloproliferative neoplasm
  40. NMR Spectroscopy → NMR spectroscopy → Nuclear magnetic resonance spectroscopy
  41. Nadolol detailed information → Nadolol → Nadolol (tablet)
  42. Nadolol drug interactions → Nadolol#Drug Interactions → Nadolol (tablet)
  43. Nadolol indications and usage → Nadolol#Adult Indications and Dosage → Nadolol (tablet)
  44. Nadolol adverse reactions → Nadolol#Adverse Reactions → Nadolol (tablet)
  45. Nadolol contraindications → Nadolol#Contraindications → Nadolol (tablet)
  46. Nadolol dosage forms and strengths → Nadolol#How Supplied → Nadolol (tablet)
  47. Nadolol dosage and administration → Nadolol#Adult Indications and Dosage → Nadolol (tablet)
  48. Nadolol labels and packages → Nadolol#Package and Label Display Panel → Nadolol (tablet)
  49. Nadolol patient counseling information → Nadolol#Patient Counseling Information → Nadolol (tablet)
  50. Nadolol how supplied storage and handling → Nadolol#How Supplied → Nadolol (tablet)

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://www.wikidoc.org/index.php/Special:DoubleRedirects"